Related references
Note: Only part of the references are listed.A curcumin analog CA-5f inhibits urokinase-type plasminogen activator and invasive phenotype of triple-negative breast cancer cells
Minjoo Kim et al.
TOXICOLOGICAL RESEARCH (2022)
Whole Aspect of Runx2 Functions in Skeletal Development
Toshihisa Komori
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Effects of GH/IGF axis on bone and cartilage
Manisha Dixit et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
Veronica Mollica et al.
CANCERS (2021)
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
George N. Tzanakakis et al.
CANCERS (2021)
Biochemical determinants of the IGFBP-3-hyaluronan interaction
Sadaf Dorandish et al.
FEBS OPEN BIO (2020)
The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)2D3 In Vivo
Tomoki Mori et al.
ENDOCRINOLOGY (2020)
Prostate-specific antigen modulates the osteogenic differentiation of MSCs via the cadherin 11-Akt axis
Longxiang Wu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis
Narelle E. McGregor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Roles of Phosphate in Skeleton
Toshimi Michigami et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Bone resorption and bone metastasis risk
Katlynn M. Mathis et al.
MEDICAL HYPOTHESES (2018)
PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormones
Maya B. Kostova et al.
PROSTATE (2018)
The Osteoclast in Bone Metastasis: Player and Target
Antonio Maurizi et al.
CANCERS (2018)
Insulin-like growth factor binding Protein-3 suppresses osteoblast differentiation via bone morphogenetic protein-2
Kaori Eguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Transforming Growth Factor-Beta and Urokinase Type Plasminoge Interplay in Cancer
Juan F. Santibanez et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2018)
The role of biomarkers in the management of bone-homing malignancies
Stella D'Oronzo et al.
JOURNAL OF BONE ONCOLOGY (2017)
Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer
Song-Chang Lin et al.
DEVELOPMENTAL CELL (2017)
Disruption of collagen/apatite alignment impairs bone mechanical function in osteoblastic metastasis induced by prostate cancer
Aiko Sekita et al.
BONE (2017)
Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases
Alexander Kirschenbaum et al.
ENDOCRINOLOGY (2016)
11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer
Francesco Ceci et al.
CLINICAL NUCLEAR MEDICINE (2015)
Anti-angiogenic activity of PSA-derived peptides
Kailash C. Chadha et al.
PROSTATE (2015)
Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment
Sandy R. Larson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Emerging Roles of Human Prostatic Acid Phosphatase
Hoon Young Kong et al.
BIOMOLECULES & THERAPEUTICS (2013)
Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications
Spyros G. Pneumaticos et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
The IRE1α-XBP1 Pathway Positively Regulates Parathyroid Hormone (PTH)/PTH-related Peptide Receptor Expression and Is Involved in PTH-induced Osteoclastogenesis
Takahide Tohmonda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Adenosine and bone metabolism
Aranzazu Mediero et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
A2B Adenosine Receptor Promotes Mesenchymal Stem Cell Differentiation to Osteoblasts and Bone Formation in Vivo
Shannon H. Carroll et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation
Alexander Kirschenbaum et al.
SKELETAL BIOLOGY AND MEDICINE I (2011)
Enzymatically Active Prostate-Specific Antigen Promotes Growth of Human Prostate Cancers
Simon A. Williams et al.
PROSTATE (2011)
PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo
A. P. Cumming et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
Pathogenesis of Osteoblastic Bone Metastases From Prostate Cancer
Toni Ibrahim et al.
CANCER (2010)
Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappa B, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteoblast-like cells
Tisheeka R. Graham et al.
CANCER SCIENCE (2010)
Tumor-stroma co-evolution in prostate cancer progression and metastasis
Sajni Josson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Osteoblasts suppress high bone turnover caused by osteolytic breast cancer in-vitro
Roman Krawetz et al.
EXPERIMENTAL CELL RESEARCH (2009)
Prostatic acid phosphatase, a neglected ectonucleotidase
Herbert Zimmermann
PURINERGIC SIGNALLING (2009)
Transforming growth factor-β prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling
Cecilie Dufour et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions
Jinhui Liao et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover
Zhong Dong et al.
NEOPLASIA (2008)
Immunohistochemical analysis of low-grade and high-grade prostate carcinoma:: relative changes of parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand
Francisco C. Perez-Martinez et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?
Simon A. Williams et al.
PROSTATE (2007)
Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts
Hiroyuki Yonou et al.
PROSTATE (2007)
Prostate-specific antigen induces apoptosis of osteoclast precursors: Potential role in osteoblastic bone metastases of prostate cancer
Masato Goya et al.
PROSTATE (2006)
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases
Theresa A. Guise et al.
CLINICAL CANCER RESEARCH (2006)
Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2
N Nadiminty et al.
CLINICAL CANCER RESEARCH (2006)
Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells
H Koch et al.
STEM CELLS AND DEVELOPMENT (2005)
Preferential production of latent transforming growth factor β-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen
SL Dallas et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Mechanisms of disease: Mechanisms of bone metastasis
GD Roodman
NEW ENGLAND JOURNAL OF MEDICINE (2004)
PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway
XL Shen et al.
EXPERIMENTAL CELL RESEARCH (2004)
Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines
M Zayzafoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
An overview of the kallikrein gene families in humans and other species: Emerging candidate tumour markers
GM Yousef et al.
CLINICAL BIOCHEMISTRY (2003)
Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor - Contrasting interactions of full-length and soluble forms of uPAR
JL Kreiling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer
Y Miyata et al.
PROSTATE (2003)
Expression of parathyroid hormone (PTH)-related peptide (PTHrP) and PTH/PTHrP receptor in osteoclast-like giant cells
M Nakashima et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells
H Kondo et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Proteolysis of latent transforming growth factor-β (TGF-β)-binding protein-1 by osteoclasts -: A cellular mechanism for release of TGF-β from bone matrix
SL Dallas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3
H Koistinen et al.
PROSTATE (2002)
Prostate-specific antigen induces osteoplastic changes by an autonomous mechanism
H Yonou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-β (TGF-β) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells:: lack of IGF-independent IGFBP-3 effects
C Schmid et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer
AP Mazar
ANTI-CANCER DRUGS (2001)
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone
J Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
A N-terminal PTHrP peptide fragment void of a PTH/PTHrP-receptor binding domain activates cardiac ETA receptors
KD Schluter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption
JW Chiao et al.
BRITISH JOURNAL OF CANCER (2000)
Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
K Kobayashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
